✦ LIBER ✦

A nomogram to reduce errors in paediatric drug dose calculations

✍ Scribed by M.E. Wilson; K.R. MacLeod

Book ID: 108615338
Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 176 KB
Volume: 37
Category: Article
ISSN: 0003-2409
DOI: 10.1111/j.1365-2044.1982.tb01861.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Labeling as a Tool to Reduce Drug Error

Labeling as a Tool to Reduce Drug Error in Anesthesia Practice

✍ ALNASSER, B 📂 Article 📅 2005 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 43 KB

Numerical errors in impurity transport c

Numerical errors in impurity transport calculations through the boundary of finite-area cells, and a new practical model to reduce such errors

✍ S. Ushio; K. Nishi; J. Ueda 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 489 KB

Refrigerating eggs prior to incubation a

Refrigerating eggs prior to incubation as a way of reducing error in calculating developmental age in imprinting experiments

✍ Gilbert Gottlieb 📂 Article 📅 1963 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Moderate Dose, Three-Drug Therapy With N

Moderate Dose, Three-Drug Therapy With Niacin, Lovastatin, and Colestipol to Reduce Low-Density Lipoprotein Cholesterol <100 mg/dl in Patients With Hyperlipidemia and Coronary Artery Disease

✍ B.Greg Brown; MD; PhD; Joanna Bardsley; MD; Drew Poulin; BS; Lynn A. Hillger; Ph 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Low-dose prednisolone in addition to the

Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: A two-year randomized trial

✍ Björn Svensson; Annelies Boonen; Kristina Albertsson; Désirée van der Heijde; Ca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 208 KB 👁 2 views

## Abstract ## Objective To assess the efficacy of low‐dose prednisolone on joint damage and disease activity in patients with early rheumatoid arthritis (RA). ## Methods At the start of their initial treatment with a disease‐modifying antirheumatic drug (DMARD), patients with early (duration ≤1